Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Stock Short Interest Declines 73.5%

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) saw a large decline in short interest during the month of September. As of September 15th, there was short interest totaling 7,633 shares, a decline of 73.5% from the August 31st total of 28,773 shares. Approximately 0.2% of the company’s shares are sold short. Based on an average trading volume of 42,981 shares, the short-interest ratio is currently 0.2 days.

Institutional Trading of Invesco Pharmaceuticals ETF

A number of institutional investors have recently added to or reduced their stakes in the business. IFP Advisors Inc grew its position in Invesco Pharmaceuticals ETF by 31.3% in the fourth quarter. IFP Advisors Inc now owns 440 shares of the company’s stock valued at $46,000 after acquiring an additional 105 shares in the last quarter. Rockefeller Capital Management L.P. grew its stake in Invesco Pharmaceuticals ETF by 20.5% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,230 shares of the company’s stock valued at $129,000 after purchasing an additional 209 shares in the last quarter. Geneos Wealth Management Inc. raised its position in shares of Invesco Pharmaceuticals ETF by 24.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,722 shares of the company’s stock valued at $179,000 after purchasing an additional 335 shares in the last quarter. Fifth Third Bancorp acquired a new stake in shares of Invesco Pharmaceuticals ETF during the first quarter worth approximately $36,000. Finally, Global Assets Advisory LLC acquired a new position in Invesco Pharmaceuticals ETF during the 1st quarter worth $42,000.

Invesco Pharmaceuticals ETF Stock Performance

PJP opened at $126.82 on Friday. Invesco Pharmaceuticals ETF has a 1 year low of $90.43 and a 1 year high of $131.68. The company’s 50 day simple moving average is $125.49 and its 200 day simple moving average is $114.59. The stock has a market capitalization of $568.15 million, a PE ratio of 15.59 and a beta of 0.45.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.